Chronic hepatitis B in children with or without malignancies: A 13-year follow-up

Table 2 Initial laboratory and liver biopsy findings of the patients in both groups

	Group 1, n = 24	Group 2, n = 25	P value
HBeAg (+)	24/24	25/25
HBsAg (+)	24/24	25/25
1HBV DNA > 105 copies/mL	24/24	25/25
1ALT N	9	8	0.350
ULNX2	11	10
ULNX3	4	7
2Alpha fetoprotein	2.35 ± 1.84 (1.84)	1.66 ± 0.54 (1.60)	0.053
Albumin	4.27 ± 0.22	4.22 ± 0.32	0.654
INR	1.08 ± 0.07	1.07 ± 0.07	0.894
2Hepatitis activation index (mean ± SD)	5.41 ± 2.94 (5.00)	5.91 ± 2.52 (5.00)	0.644
2Fibrosis (mean ± SD)	1.38 ± 1.15	1.04 ± 0.64	0.441
Treated patients (INF-α and LAM)	15	17

¹χ² test;

²Mann Whitney U test. HBeAg: Hepatitis B e antigen; HBsAg: Hepatitis B surface antigen; HBV: Hepatitis-B virus; ALT: Aminotransferase.